Navigation Links
UK company to demonstrate their commercially effective graphene production process
Date:4/6/2012

Haydale, a wholly owned subsidiary of British company Innovative Carbon Limited today announces that they will be exhibiting at Graphene 2012 from 10th April to 13th.

Graphene, a sheet of carbon just one atom thick, has been described as the new wonder material. First isolated at Manchester University in 2004, for which the team was awarded a Nobel Prize, the race has been on to produce it commercially. To support this work the UK Government recently announced a 50m investment into developing a research and technology hub to explore the commercialisation of Graphene. Similarly the EU has pledged 100m annually for the next 10 years looking at the exploitation of Graphene in Information and Communication Technology (ICT) and consumer applications.

The major players in this industry will be coming together at an international conference in Brussels next week. Haydale, based in South Wales and with close ties to leading UK Universities will be part of the British contingent. Their unique patented plasma based technology, which is winning plaudits around the world, enables the scaleable production of Graphene Nano Platelets (GNPs) from powdered graphite. The process can now produce commercial quantities of a consistently high quality in an economic and environmentally friendly way.

There are a vast array of applications for Graphene, but in Brussels Haydale will be displaying a range of current offerings produced via their novel patented process, including a transparent conductive membrane that could be a competitor of Indium Tin Oxide (one of the key components in photovoltaic cells and touch screen devices); graphene loaded polymer pellets; samples of GNPs and a conductive ink, capable of replacing some silver based products. The ink has many applications and could positively impact on the radio frequency identification and security industry. Haydale will have their scientists and engineers at the show to discuss these and other potential applications and to explain their split plasma process and the characterisation capability of the technology.

Haydale has now started to offer a range of GNPs and other materials to the open market under the brand HDPlas.

Critically, organisations can now use the HDPlas product range for product prototyping and analysis. Haydale offers expertise in running pilot trials to evaluate the effect their GNPs have on the client's materials and products and crucially assessing their suitability for large scale production. The key to take up is to know that commercial quantities are then available.

Haydale, who are moving to new purpose built state of the art facilities in South Wales, is now able to supply HDPlas from stock as well as to order. A technical analysis sheet, which includes typical characterisation data and representational images, has been prepared and will accompany the goods so that the buyer can instantly see the product specification without needing to spend valuable time and resource in independent verification procedures.

Commenting, Chairman Tony Belisario said:

"We are all very excited by the opportunity our patented process offers as a critical element of material replacement for enhanced performance of a vast array of potential applications. The market is looking for ways of using the new wonder material Graphene and we believe that we have the process that can now make the commercial quantities required by global companies. The cutting edge technology has been peer reviewed and we can now do "what it says on the tin". We have proved we can personalise solutions to a clients specific needs in a cost effective, environmentally friendly and innovative way. Graphene 2012 is a perfect place to launch our technology and we expect significant interest in Haydale."


'/>"/>

Contact: Trevor Phillips
trevor.phillips@hermesfinancialpr.co.uk
44-788-915-3628
Hermes Financial Public Relations
Source:Eurekalert

Related biology technology :

1. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
2. Nycomed, a Takeda Company, Launches OmnarisĀ® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
3. Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
5. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
6. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
7. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
8. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
9. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
10. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
11. Monsanto Declared Worst Company of 2011 by NaturalSociety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... DUBLIN , March 27, 2017 ... access to a comprehensive library of reports on Valero ... the transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... is biofuel production to go green. Ethanol today, even though ...
(Date:3/27/2017)... Israel , March 27, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... party insurance coverage option for U.S. consumers who want ... DarioHealth has signed strategic alliance agreements with ... verify insurance coverage benefits, and if approved, will supply ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... Global Strategic Business Report" report to their offering. ... This report analyzes the ... Million. Annual estimates and forecasts are provided for the period 2014 ... secondary research. The report profiles 25 companies including ...
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
Breaking Biology Technology:
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/20/2017)... 2017 PMD Healthcare announces the release of ... Management System (WMS), a remote, real-time lung health monitoring ... Healthcare is a Medical Device, Digital Health, and Chronic ... creating innovative solutions that empower people to improve their ... PMD developed the first ever personal spirometer, Spiro PD, ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today announces that ... uncover insights to support its reporting, help direct future campaigns, and ... youth charity will be using Brandwatch Analytics social listening and analytics ... of the topics and issues that are a priority for its ... "Until recently ...
Breaking Biology News(10 mins):